The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores
Cancer Medicine · 2024
DOI: 10.1002/cam4.70139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Josh McGovern und 10 weiteren Autor:innen. Beteiligte Einrichtung: Academic Unit of Surgery, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Palliative Care, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The present study sought to examine the relationships between systemic inflammatory composite ratios/cumulative scores, magnitude of systemic inflammatory response (SIR) and survival in good performance status patients (ECOG‐PS 0/1) with advanced NSCLC receiving palliative radiotherapy.
Methods
Systemic inflammatory composite ratios/cumulative scores included the neutrophil‐lymphocyte ratio (NLR), platelet‐lymphocyte ratio (PLR), lymphocyte‐monocyte ratio (LMR), C‐reactive protein, (CRP)‐albumin ratio (CAR), neutrophil‐ lymphocyte score (NLS), platelet‐lymphocyte score (PLS), lymphocyte‐monocyte score (LMS), neutrophil‐platelet score (NPS), modified Glasgow prognostic score (mGPS). The magnitude of SIR was determined by serum CRP concentration, with a median CRP concentration of >10 m mg/L considered to be systemically inflamed. Relationships between systemic inflammatory composite ratios/ cumulative scores and clinicopathological characteristics were examined using chi‐square analysis. Relationships between overall survival (OS) and systemic inflammatory composite ratios/ cumulative scores were examined using cox regression analysis.
Results
479 patients were included. 48% ( n = 231) of patients were male and 70% ( n = 338) were ≥65 years of age. 29% ( n = 140) patients were ECOG‐PS 0 and 71% ( n = 339) were ECOG‐PS 1. 98% ( n = 469) of patients died during follow‐up. The median survival was 5 months (2–11). A similar prevalence of systemic inflammation was noted across the various ratios/scores (NLR >3 68%; LMR 150 70%; CAR >0.20 83%; NLS ≥1 66%; LMS ≥1 71%; NPS≥1 50%; PLS≥1 60% and mGPS≥1 75%). Despite not considered to be systemically inflamed, an NLR 10 mg/L. When adjusted for ECOG‐PS, CAR>0.40 ( p < 0.001) and mGPS 2 ( p < 0.05) remained significantly associated with OS.
Conclusion
Liver‐based measures of systemic inflammation (CAR and mGPS) appear more reliable for the quantification of the magnitude of SIR and have prognostic value in patients with advanced NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Academic Unit of Surgery, University of Glasgow, Glasgow, UK.
- Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, UK.
- Department of Respiratory Medicine, Glasgow Royal Infirmary, Glasgow, UK.
- Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
ORCID-Profile: Josh McGovern
Zitieren
APA
McGovern, J., O'Rourke, F., Will, S., Nguyen, H. T. N., Cranfield, E., Maseland, C., MacLeod, N., Maclay, J. D., Laird, B. J., Dolan, R. D., & McMillan, D. C. (2024). The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores. Cancer Medicine. https://doi.org/10.1002/cam4.70139
Vancouver
McGovern J, O'Rourke F, Will S, Nguyen HTN, Cranfield E, Maseland C, et al. The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores. Cancer Medicine. 2024. doi:10.1002/cam4.70139
BibTeX
@article{McGovern2024,
author = {McGovern, Josh and O'Rourke, Fraser and Will, Sarah and Nguyen, Hanh Thi Ngoc and Cranfield, Elise and Maseland, Charlotte and MacLeod, Nicholas and Maclay, John D and Laird, Barry J and Dolan, Ross D and McMillan, Donald C},
title = {The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70139}
}
EUVIMED